SAN FRANCISCO, Oct. 31, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the Rodman & Renshaw 8th Annual Healthcare Conference on Tuesday, November 7th at 12:05pm EST in the Kennedy II Room at The Palace Hotel in New York, NY.
